We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$3.15B
AUM Growth
+$299M
Cap. Flow
+$22.4M
Cap. Flow %
0.71%
Top 10 Hldgs %
63.85%
Holding
446
New
9
Increased
234
Reduced
21
Closed
20

Top Buys

Rank Stock Value
1
MSGS icon
Madison Square Garden
MSGS
+$14.3M
2
T icon
AT&T
T
+$9.13M
3
CVX icon
Chevron
CVX
+$6.76M
4
COP icon
ConocoPhillips
COP
+$6.03M
5
BA icon
Boeing
BA
+$5.66M

Sector Composition

Rank Sector Weight
1 Healthcare 44.54%
2 Communication Services 9.08%
3 Technology 8.64%
4 Consumer Discretionary 7.69%
5 Financials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
351
Monster Beverage
MNST
$87.3B
$47K ﹤0.01%
2,040
VVV icon
352
Valvoline
VVV
$3.46B
$46K ﹤0.01%
1,410
+5
+0.4% +$155
IBN icon
353
ICICI Bank
IBN
$101B
$44K ﹤0.01%
2,575
TRGP icon
354
Targa Resources
TRGP
$61.1B
$44K ﹤0.01%
992
-8,575
-90% -$332K
PXD
355
DELISTED
Pioneer Natural Resource Co.
PXD
$44K ﹤0.01%
268
+1
+0.4% +$157
KNL
356
DELISTED
Knoll, Inc.
KNL
$42K ﹤0.01%
1,630
PUK icon
357
Prudential
PUK
$32.5B
$41K ﹤0.01%
1,113
SOHO
358
DELISTED
Sotherly Hotels
SOHO
$41K ﹤0.01%
13,679
MAGN
359
Magnera Corp
MAGN
$414M
$41K ﹤0.01%
227
+2
+0.9% +$394
ALTG icon
360
Alta Equipment Group
ALTG
$190M
$39K ﹤0.01%
2,939
EDIT icon
361
Editas Medicine
EDIT
$416M
$39K ﹤0.01%
680
MDY icon
362
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.7B
$39K ﹤0.01%
80
SLNO
363
DELISTED
Soleno Therapeutics
SLNO
$39K ﹤0.01%
+2,288
New +$38.7K
NTNX icon
364
Nutanix
NTNX
$18.6B
$38K ﹤0.01%
990
SXI icon
365
Standex International
SXI
$3.18B
$38K ﹤0.01%
401
+1
+0.3% +$97
ASH icon
366
Ashland
ASH
$3.23B
$37K ﹤0.01%
418
+1
+0.2% +$90
KRE icon
367
State Street SPDR S&P Regional Banking ETF
KRE
$4.23B
$37K ﹤0.01%
559
+2
+0.4% +$137
BNY
368
Bank of New York Mellon
BNY
$104B
$36K ﹤0.01%
711
+4
+0.6% +$200
BMRN icon
369
BioMarin Pharmaceuticals
BMRN
$12.5B
$33K ﹤0.01%
400
CNI icon
370
Canadian National Railway
CNI
$72.3B
$33K ﹤0.01%
311
+1
+0.3% +$110
REZI icon
371
Resideo Technologies
REZI
$2.83B
$33K ﹤0.01%
1,116
+1,100
+6,875% +$32.6K
PINS icon
372
Pinterest
PINS
$10.6B
$32K ﹤0.01%
+400
New +$27.9K
WBK
373
DELISTED
Westpac Banking Corporation
WBK
$32K ﹤0.01%
1,667
LIN icon
374
Linde
LIN
$213B
$31K ﹤0.01%
106
SPRO icon
375
Spero Therapeutics
SPRO
$64.6M
$31K ﹤0.01%
2,215

Similar funds

Bollard Group's Q2 2021 Portfolio in Review

As of Q2 2021, Bollard Group held 446 positions worth $3.15B, up 10% from $2.85B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Bollard Group's Q2 2021 filing shows 9 new, 234 increased, 21 reduced and 20 closed positions. Its largest new stake was Vimeo: 41,444 shares worth $2.03M. The largest sale was Boston Scientific, an estimated $66.9M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Communication Services and Technology.

  • Bollard Group's largest Q2 2021 buy was Vimeo: 41,444 shares worth $2.03M.
  • Bollard Group added most to Madison Square Garden in Q2 2021, an estimated $14.3M increase.
  • Bollard Group's biggest Q2 2021 reduction was Boston Scientific, cutting an estimated $66.9M.
  • Bollard Group fully exited Fastly Inc in Q2 2021, selling an estimated $841K.
  • Bollard Group's ten largest holdings make up 64% of its $3.15B portfolio in Q2 2021.
  • Bollard Group opened 9 new positions and closed 20 in Q2 2021.
  • Bollard Group's portfolio value rose 10% quarter-over-quarter to $3.15B.

Based on Bollard Group's 13F filing for Q2 2021, filed 12 Aug 2021.